NGM Clinical Study Site

Austin, Texas 78758

0 studies enrolling now · 4 studies all time

What they study most

Bladder Urothelial Cancer, Breast Cancer, Cervical Cancer, Cholangiocarcinoma, Colorectal Carcinoma, Compensated Cirrhosis, Endocervical Cancer, Esophageal Cancer, Gastric Cancer, Geographic Atrophy, Melanoma, Mesothelioma

Studies at this site

• Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) — Completed
• Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) — Completed
• Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors — Running, not enrolling
• Study of NGM621 in Participants With Geographic Atrophy — Completed